Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease
Information source: Sandoz Korea
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Parkinson's Disease
Intervention: pramipexole (Drug); Bromocriptine (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Sandoz Korea Official(s) and/or principal investigator(s): Seongbeom Koh, MD, Principal Investigator, Affiliation: Korea University Guro Hospital
Overall contact: Kim, Phone: +82 2 768 9422
Summary
The purpose of this study is to determine whether pramipexole and bromocriptine are
effective in the treatment of non-motor symptoms in Parkinson's Disease.
Clinical Details
Official title: Effect of Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease: Multicenter, Open-label, Parallel, Randomized Study
Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: K-NMSS
Secondary outcome: K-MADRSUPDRS I/II/III K-PDQ39
Detailed description:
PRIMARY OBJECTIVE Evaluate the Improvement of Nonmotor symptom scale (NMSS) between
Pramipexole and Bromocriptine for early Parkinson's disease during 24-week treatment
SECONDARY OBJECTIVE
- Evaluate the improvement for Depression which is one of the Nonmotor symptoms
- Evaluate the improvement of clinical symptoms between two groups
- Evaluate the improvement of Quality of Life between two groups
Eligibility
Minimum age: 30 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Parkinson's disease patients in accordance with UK Queensquare Brain Bank
- modified Hoehn & Yahr stage <3
- Dopamine agents(Levodopa, dopamine agonists) naive patients, or the patients who have
discontinued the agents at least four weeks before the screening in case of using the
dopamine agents are administered before.
Exclusion Criteria:
- K-MMSE<24
- History of drug-induced Parkinsonism
- secondary parkinsonism
- History of schizophrenia or hallucination
- Requirement of treatment with anti-depressants due to depressive disorder
- Pregnant and/or breeding women
- Renal inadequacy
Locations and Contacts
Kim, Phone: +82 2 768 9422
Korea University Ansan Hospital, Ansan, Korea, Republic of; Recruiting na
Inje University Busan Paik Hospital, Busan, Korea, Republic of; Recruiting na
Youngnam University Hospital, Daegu, Korea, Republic of; Recruiting na
Kangwon Nat'l University Hospital, Kangwon, Korea, Republic of; Recruiting na
Inje university Sanggye Paik Hospital, Seoul, Korea, Republic of; Recruiting na
Korea University Anam Hospital, Seoul, Korea, Republic of; Recruiting na
Korea University Guro Hospital, Seoul, Korea, Republic of; Recruiting na
Additional Information
Starting date: February 2012
Last updated: September 3, 2012
|